Renal Cancer

>

Latest News

New-Onset T2D Tied to Higher Risk of Obesity-Related Cancer: Daily Dose / image credit: ©New Africa/AdobeStock
New-Onset T2D Tied to Higher Risk of Obesity-Related Cancer: Daily Dose

June 3rd 2025

Your daily dose of the clinical news you may have missed.

ASCO 2025: GLP-1 Receptor Agonists Linked to Modest Reduction in Obesity-Related Cancer Risk
ASCO 2025: GLP-1 Receptor Agonists Linked to Modest Reduction in Obesity-Related Cancer Risk

May 28th 2025

New-Onset Type 2 Diabetes Tied to Higher Risk of Specific Obesity-Related Cancers
New-Onset Type 2 Diabetes Tied to Higher Risk of Specific Obesity-Related Cancers

April 24th 2025

GLP-1RAs Reduce Risk of Some Obesity-Related Cancers in Patients with T2D: Daily Dose / image credit: ©New Africa/AdobeStock
GLP-1RAs Reduce Risk of Some Obesity-Related Cancers in Patients with T2D: Daily Dose

July 15th 2024

GLP-1RAs Linked to Decreased Risk of Some Obesity-Related Cancers in Patients with T2D
GLP-1RAs Linked to Decreased Risk of Some Obesity-Related Cancers in Patients with T2D

July 8th 2024

More News

© 2025 MJH Life Sciences

All rights reserved.